{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:27:44Z","timestamp":1777332464441,"version":"3.51.4"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background and aims<\/jats:title><jats:p>The burden hepatitis C infection in people with history or current drug use suppose a high risk of hepatic complications and transmission infectious disease. This population is poor linked to heath system and is difficult to achieve them and support treatment because they have high rates of lost follow-up. Our aim was to evaluate an intervention for the diagnosis and treatment of chronic hepatitis C and HIV in this population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Six-hundred and eighty-three people attended in Drugs and Addictions Centers (DAC) were asked to participate in health counseling and provide blood sample for test HCV, HIV, and syphilis from April 2019 to June 2020. Totally 556 subjects were surveyed and tested. All of them were assigned to a patient navigation program to improve health education and linking to the sanitary system. Hepatitis C infection patients were evaluated in an ampliated medical consult to evaluate hepatic stage with transient liver elastography and initiated Direct Acting Antivirals to achieve Sustained Viral Response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 556 patients who agreed to participate in the study, 33 (5.9%) had active HCV infection. Of the 33 patients infected with HCV, three were lost to follow-up once the diagnosis of HCV infection was made. Twenty-eight patients (93.3%) completed treatment and 26 achieved Sustained Viral Response (78.8%). Of the 30 patients, seven (23.3%) had advanced fibrosis, and of these, four (16.6%) had liver cirrhosis. One of the cirrhotic patients had hepatic space-occupying lesions at the baseline evaluation and was diagnosed with hepatocarcinoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study suggests that the implementation of strategies based on personalized intervention models can contribute to the control of HCV infection in DAC users.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1092960","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T12:22:38Z","timestamp":1675340558000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of a comprehensive strategy for the detection and treatment of hepatitis C infection in a population attending addiction centers"],"prefix":"10.3389","volume":"11","author":[{"given":"Diana","family":"Corona-Mata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngela","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ruiz-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Ruiz-C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartolom\u00e9","family":"de la Fuente Darder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"C\u00e1ceres-Anillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"de Gu\u00eda Castro-Granados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Lizaur-Barbudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Victoria Cabrera-Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justa","family":"Redondo-\u00c9cija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Aparicio-Aparicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Manchado-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Cobos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"P\u00e9rez-Valero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1053\/j.gastro.2018.10.024","article-title":"Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges","volume":"156","author":"Baumert","year":"2019","journal-title":"Gastroenterology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/cld.978","article-title":"Hepatitis C virus elimination by 2030: conquering mount improbable","volume":"16","author":"Dhiman","year":"2021","journal-title":"Clin Liver Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/liv.14363","article-title":"Micro-elimination of hepatitis C virus","volume":"40","author":"Hollande","year":"2020","journal-title":"Liver Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/QAD.0000000000003112","article-title":"The hepatitis C cascade of care in HIV\/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences","volume":"36","author":"Fursa","year":"2022","journal-title":"AIDS."},{"key":"B5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/v14030482","article-title":"HCV elimination in central Europe with particular emphasis on microelimination in prisons","volume":"14","author":"Flisiak","year":"2022","journal-title":"Viruses"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1093\/cid\/cit296","article-title":"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy","volume":"57","author":"Martin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10096-016-2822-6","article-title":"Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish National hepatitis C strategy","volume":"36","author":"Rivero-Juarez","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41395-018-0157-x","article-title":"Microenvironment eradication of hepatitis C: a novel treatment paradigm","volume":"113","author":"Cuadrado","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/hiv.12715","article-title":"Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients","volume":"20","author":"Rivero-Juarez","year":"2019","journal-title":"HIV Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","article-title":"Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): a systematic review and meta-analysis","volume":"26","author":"Smith","year":"2015","journal-title":"Int J Drug Policy."},{"key":"B11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/10826084.2021.1879149","article-title":"Novel routes of potential hepatitis C virus transmission among people who inject drugs: secondary blood exposures related to injection drug use","volume":"56","author":"Goldshear","year":"2021","journal-title":"Subst Use Misuse."},{"key":"B12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jvh.13634","article-title":"Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination","volume":"29","author":"Forns","year":"2022","journal-title":"J Viral Hepat"},{"key":"B13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.drugpo.2022.103588","article-title":"Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: a systematic review and practical considerations from an expert panel consultation","volume":"1","author":"Schwarz","year":"2022","journal-title":"Int J Drug Policy."},{"key":"B14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.drugpo.2019.06.021","article-title":"Point-of-care hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department","volume":"72","author":"Hutton","year":"2019","journal-title":"Int J Drug Policy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/jvh.13664","article-title":"The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: an Australian pilot study","volume":"29","author":"Howell","year":"2022","journal-title":"J Viral Hepat"},{"key":"B16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.11622\/smedj.2020116","article-title":"Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study","volume":"63","author":"Hsiang","year":"2022","journal-title":"Singapore Med J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C guidance 2019 update: American Association for the study of liver diseases-infectious diseases society of America recommendations for testing, managing, and treating hepatitis C Virus infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series?","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.eimce.2019.06.003","article-title":"The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy","volume":"37","author":"Garc\u00eda","year":"2019","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"22146","DOI":"10.7448\/IAS.20.1.22146","article-title":"Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there","volume":"20","author":"Grebely","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/PHH.0000000000000519","article-title":"Check Hep C: a community-based approach to hepatitis C diagnosis and linkage to care in high-risk populations","volume":"24","author":"Ford","year":"2018","journal-title":"J Public Health Manag Pract."},{"key":"B23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","article-title":"Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis","volume":"7","author":"Cunningham","year":"2022","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.04.031.","article-title":"Patient navigation increases linkage to care and receipt of direct-acting antiviral therapy in patients with hepatitis C","author":"Strebe","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/cid\/cix798","article-title":"Cost-effectiveness of one-time hepatitis c screening strategies among adolescents and young adults in primary care settings","volume":"66","author":"Assoumou","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta7220","article-title":"The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation","volume":"7","author":"Loveman","year":"2003","journal-title":"Health Technol Assess"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1097\/QAD.0000000000000395","article-title":"Systematic review of strategies to increase men's HIV-testing in sub-Saharan Africa","volume":"28","author":"Hensen","year":"2014","journal-title":"AIDS."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pec.2009.02.011","article-title":"A systematic review of the literature reporting on studies that examined the impact of interactive, computer-based patient education programs","volume":"77","author":"Fox","year":"2009","journal-title":"Patient Educ Couns."},{"key":"B29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/sextrans-2012-050655","article-title":"Unlocking the potential: longitudinal audit finds multifaceted education for general practice increases HIV testing and diagnosis","volume":"89","author":"Pillay","year":"2013","journal-title":"Sex Transm Infect."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0191980","DOI":"10.1371\/journal.pone.0191980","article-title":"Patient navigators for people with chronic disease: a systematic review","volume":"13","author":"McBrien","year":"2018","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.2105\/AJPH.2013.301458","article-title":"A randomized trial of a hepatitis care coordination model in methadone maintenance treatment","volume":"103","author":"Masson","year":"2013","journal-title":"Am J Public Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/liv.14283","article-title":"Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients","volume":"40","author":"Ing Lorenzini","year":"2020","journal-title":"Liver Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhep.2019.02.018","article-title":"Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy","volume":"71","author":"Mac\u00edas","year":"2019","journal-title":"J Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1111\/liv.14152","article-title":"Staying hepatitis C negative: a systematic review and meta-analysis of cure and reinfection in people who inject drugs","volume":"39","author":"Latham","year":"2019","journal-title":"Liver Int."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1092960\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T12:22:41Z","timestamp":1675340561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1092960\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":34,"alternative-id":["10.3389\/fpubh.2023.1092960"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1092960","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"article-number":"1092960"}}